The spectrum of MEFV gene mutations and genotype-phenotype correlation in Egyptian patients with familial Mediterranean fever

Fahmy T. Ali, Mostafa M. Elhady, Hanan H. Abbas, AbdAllah Y. Mandouh


Background: Familial Mediterranean fever (FMF) is an autosomal recessive disease mainly affecting subjects of the Mediterranean origin. It is an auto-inflammatory periodic disorder that is caused by mutations in the Mediterranean fever gene (MEFV) located on chromosome 16.

Methods: The current study was designed to assess the prevalence and frequency of different MEFV gene mutations among 104 FMF clinically diagnosed Egyptian patients and to evaluate the change extent in the values of some biochemical markers (ESR, CRP, Fibrinogen-C, SAA and IL1) in different participants with different FMF severity scores.

Results: According to allele status 28 patients (27%) were homozygous mutation carriers, 38 (36.5%) were with compound heterozygous mutations and 38 (36.5%) were identified as heterozygous for one of the studied mutations. Of the studied mutations, M694I, E148Q, V726A, M680I, and M694V accounted for 28.1%, 26.8%, 16.9%, and 11.3% of mutations respectively. The R761H and P369S mutations were rarely encountered mutations (1.4%). The clinical features with M694I were associated with more severe clinical course. There is a drastic elevation in the levels of estimated parameters as their levels were increased as long as the severity of the disease increased.

Conclusions: The diagnosis of FMF cannot be performed on the basis of genetic testing or clinical criteria alone. So, we recommended the combination between clinical and molecular profiling for FMF diagnosis and scoring.


Allele frequency, ASO-PCR, Egyptian population, FMF, MEFV gene

Full Text:



Yackov M, Eli M, Eisenstein M. Update on auto-inflammatory diseases and familial Mediterranean fever. IMAJ. 2016;18:221-4.

Ozcakar Z, Yalcinkaya F, Yuksel S, Acar B, Gokmen D, Ekim M. Possible effect of subclinical inflammation on daily life in familial Mediterranean fever. Clin Rheumatol. 2006;25:149-52.

Pras M. Familial Mediterranean fever: from the clinical syndrome to the cloning of the pyrin gene. Scand J Rheumatol. 1998;27:92-7.

Livneh A, Langevitz P, Zemer D, Padeh S, Migdal A, Sohar E, Pras M. Criteria for the diagnosis of Familial Mediterranean Fever. Arthritis Rheum. 1997;40:1879-85.

Eldad BC, Micha S. Familial Mediterranean fever. Lancet. 1998;351(28):659-64.

Samuels J, Aksentijevich I, Torosyan Y. Familial Mediterranean fever at the millennium. Clinical spectrum, ancient mutations, and a survey of 100 American referrals to the national institutes of health. Medicine (Baltimore). 1998;77(4):268-97.

Dlugosch J, Altrock G, Klepzig H. Familial Mediterranean fever (familial paraoxysmal polyserositis). Dtsch Med Wochenschr. 2003;128(27):1479-82.

Talaat H, Mohamed F, Nihal M, Mohamed A. The expanded clinical profile and the efficacy of colchicine therapy in Egyptian children suffering from familial mediterranean fever: a descriptive study. Italian J Pediatr. 2012;38:66.

Padeh S, Gerstein M, Berkun Y. Colchicine is a safe drug in children with familial Mediterranean fever. J Pediatr. 2012;162:1142-6.

Papin S, Cuenin S, Agostini L. The SPRY domain of pyrin, mutated in familial Mediterranean fever patients, interacts with inflammasome components and inhibits pro IL- 1β processing. Cell Death and Differentiation. 2007;14(8):1457-66.

Lachmann H, Sengul B, Yavuzsen T, Booth D, Booth S, Bybee A. Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatology (Oxford). 2006;45:746-50.

Westergren A. The technique of the red cell sedimentation reaction. American Rev Tuberculosis. 1926;14:94-100.

El-garf A, Salah S, Iskander I, Salah H, Amin S. MEFV mutations in Egyptian patients suffering from familial Mediterranean fever: analysis of 12 gene mutations. Rheumatol Int. 2010;30(10):1293-8.

Settin A, El-Baz R, AbdRasool M, El-Khalegy H, El-Sayed O, El-Bendary M, et al. Clinical and molecular diagnosis of familial Mediterranean fever in Egyptian Children. J Gastrointestin Liver Dis. 2007;16(2):141-5.

Duşunsel R, Dursun I, Gündüz Z, Poyrazoğlu MH, Gürgöze MK, Dundar M. Genotype-phenotype correlation in children with Familial Mediterranean Fever in a Turkish population. Pediatr Int. 2008;50(2):208-12.

Ebru O, Sukriye D, Deniz E, Huseyin Y, Halit E. Familial Mediterranean fever: a retrospective clinical and molecular study in the East of Anatolia region of Turkey. Open Rheumatol J. 2010;4:1-6.

Tunca M, Akar S, Onen F, Ozdogan H, Kasapcopur O, Yalcinkaya F, et al. Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine (Baltimore). 2005;84:1-11.

Yalçınkaya F, Çakar N, Mısırlıoğlu M, Tumer N, Akar N, Tekin M, et al. Genotype-phenotype correlation in a large group of Turkısh patients with familial Mediterranean fever: evidence for mutation-independent amyloidosis. Rheumatology. 2000;39(1):67-72.

Touitou I. The spectrum of familial Mediterranean fever (FMF) mutations. Eur J Hum Genet. 2001;9:473-83.

Wahadneh A, Habahbeh Z, Md AQ, Abedalgani F, Alzabn S. Genotype analysis of children with familial Mediterranean fever at King Hussein Medical Center. JRMS J. 2010;17:80-3.

Eisenberg S, Aksentijevich I, Deng Z, Kastner D, Matzner Y. Diagnosis of familial Mediterranean fever by a molecular genetics method. Ann Intern Med. 1998;129:539-42.

Dode C, Pecheux C, Cazeneuve C, Cattan D, Dervichian M, Goossens M, et al. Mutations in the MEFV gene in a large series of patients with a clinical diagnosis of familial Mediterranean fever. Am J Med Genet. 2000;92(4):241-6.

Oztuzcu S, Ulasli M, Ergun S, Igci Y, Igci M, Bayraktar R, et al. Screening of common and novel familial Mediterranean fever mutations in south-east part of Turkey. Mol Biol Rep. 2014;41:2601-7.

Belmahi L, Sefiani A, Fouveau C, Feingold J, Delpech M, Grateau G. Prevalence and distribution of MEFV mutations among Arabs from the Maghreb patients suffering from familial Mediterranean fever. C R Biol. 2006;329:71-4.

Ibrahim G, Khalil F, Mostafa F, Fawzy M, Said M, Omar A, et al. (2010): Analysis of common MEFV mutations in Egyptian patients with familial Mediterranean fever: molecular characterization of the disease. Br J Biomed Sci. 21010;67:202-7.

Gunesacar R, Celik M, Arica V, Elmacioglu S, Ozturk O. Frequency of MEFV gene mutations in Hatay province, Mediterranean region of Turkey and report of a novel missense mutation (I247V). Gene. 2014;546:195-9.

Kocakap S, Gunel-Ozcan A, Cabuk F, Ensari C. The frequency of familial Mediterranean fever gene mutations and genotypes at Kirikkale and comparison with the mean of regional MEFV mutation frequency of Turkey. Mol Biol Rep. 2014;41:1419-26.

Ece A, Cakmak E, Uluca U, Kelekci S, Yolbas I, Gunes A, et al. The MEFV mutations and their clinical correlations in children with familial Mediterranean fever in southeast Turkey. Rheumatol Int. 2014;34:207-12.

Dundar M, Emirogullari E, Kiraz A, Taheri S, Baskol M. (2011): Common familial Mediterranean fever gene mutations in a Turkish cohort. Mol Biol Rep. 2011;38:5065-9.

Ceylan G, Ceylan C, Ozturk E. Frequency of alterations in the MEFV gene and clinical signs in familial Mediterranean fever in Central Anatolia, Turkey. Genet Mol Res. 2012;11:1185-94.

Akin H, Onay H, Turker E, Cogulu O, Ozkinay F. MEFV mutations in patients with Familial Mediterranean Fever from the Aegean region of Turkey. Mol Biol Rep. 2010;37:93-8.

Dogan H, Koca Y, Erden G, Karaaslan Y, Bozat H. Evaluating MEFV mutation frequency in Turkish familial Mediterranean fever suspected patients and gender correlation: a retrospective study. Mol Biol Rep. 2012;39:6193-6.

Neto N, De Carvalho J. The use of inflammatory laboratory tests in rheumatology. Rev Bras Reumatol. 2009;49(4):421-30.

Korkmaz C, Ozdogan H, Kasapcopur O, Yazici H. Acute phase response in familial Mediterranean fever. Ann Rheum Dis. 2002;61:79-81.

Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. New Engl J Med. 1999;340:448-54.